Leadership Overview
Smith & Nephew has 7 executives leading key functions including strategy, operations, human resources, financial oversight, and wound management.
Focused on advancing medical technology, Smith & Nephew delivers innovative healthcare solutions to improve patient outcomes globally. The organization maintains a commitment to excellence in orthopaedic reconstruction and sports medicine through rigorous research and development.
Focused on advancing medical technology, Smith & Nephew delivers innovative healthcare solutions to improve patient outcomes globally. The organization maintains a commitment to excellence in orthopaedic reconstruction and sports medicine through rigorous research and development.
Leadership Roles at Smith & Nephew
Deepak Nath - Chief Executive Officer
Deepak Nath, the Chief Executive Officer at Smith & Nephew, directs the overarching strategic vision for the global medical technology enterprise. Nath oversees the development of advanced medical devices, ensuring alignment between clinical innovation and market demands across orthopaedic reconstruction and sports medicine sectors. By managing complex international operations, the Chief Executive Officer drives sustainable growth and maintains the company's competitive position on the London Stock Exchange. Deepak Nath coordinates with the board to prioritize investments in high-growth clinical therapies while optimizing manufacturing efficiency. This leadership role involves fostering partnerships with healthcare providers to expand the reach of advanced wound care solutions. Through disciplined execution of corporate objectives, Nath secures long-term value for stakeholders. Ultimately, the Chief Executive Officer maintains the integrity of the brand while navigating the evolving landscape of global healthcare equipment manufacturing.
Duane Dorn - Senior Vice President, Chief Financial Officer - Global Orthopaedics
Duane Dorn, the Senior Vice President, Chief Financial Officer - Global Orthopaedics at Smith & Nephew, manages the financial health and fiscal planning for the orthopaedic reconstruction division. Dorn oversees capital allocation, budgeting, and financial reporting to ensure the profitability of joint reconstruction and trauma device portfolios. By analyzing market trends in the orthopaedic sector, the Senior Vice President, Chief Financial Officer - Global Orthopaedics drives cost-efficiency and resource optimization across global manufacturing operations. Duane Dorn collaborates with commercial leaders to evaluate the financial viability of new clinical therapies and surgical instruments. This leadership role involves maintaining rigorous financial controls to support the company's growth objectives in the competitive medical device market. Through strategic financial planning, Dorn ensures that the orthopaedic division remains a primary contributor to the company's overall revenue. Ultimately, the Senior Vice President, Chief Financial Officer - Global Orthopaedics secures the fiscal foundation necessary for continued innovation in orthopaedic care.

Nicolas Celiz - Global Interim Chief Financial Officer, Manufacturing Operations, Quality & Regulatory Affairs
Nicolas Celiz, the Global Interim Chief Financial Officer, Manufacturing Operations, Quality & Regulatory Affairs at Smith & Nephew, directs the financial oversight of production facilities and regulatory compliance frameworks. Celiz manages the budgetary requirements for manufacturing systems, ensuring that quality standards and regulatory filings align with fiscal targets. By monitoring the costs associated with global supply chains and quality assurance, the Global Interim Chief Financial Officer, Manufacturing Operations, Quality & Regulatory Affairs optimizes operational expenditures. Nicolas Celiz coordinates with quality control teams to mitigate financial risks related to product manufacturing and regulatory shifts. This role involves balancing the need for high-quality medical device production with the necessity of maintaining lean operational costs. Through precise financial management, Celiz supports the company's commitment to safety and efficacy in all healthcare solutions. Ultimately, the Global Interim Chief Financial Officer, Manufacturing Operations, Quality & Regulatory Affairs ensures that manufacturing processes remain both compliant and financially sustainable.
Ted Melo - Senior Vice President, Chief Financial Officer Global Advanced Wound Management and Head of Finance Global Research and Development
Ted Melo, the Senior Vice President, Chief Financial Officer Global Advanced Wound Management and Head of Finance Global Research and Development at Smith & Nephew, oversees the financial strategy for the wound management business and the research and development pipeline. Melo manages the allocation of funds for clinical innovation, ensuring that R&D investments yield high-impact medical solutions. By evaluating the financial performance of advanced wound care products, the Senior Vice President, Chief Financial Officer Global Advanced Wound Management and Head of Finance Global Research and Development drives profitability in this critical segment. Ted Melo coordinates with scientific teams to align research budgets with long-term commercial goals. This leadership role involves rigorous financial modeling to support the development of next-generation surgical instruments and therapies. Through strategic fiscal management, Melo ensures that the company maintains its edge in medical technology. Ultimately, the Senior Vice President, Chief Financial Officer Global Advanced Wound Management and Head of Finance Global Research and Development secures the resources needed for sustained innovation.
Rebecca Carreon - Executive Assistant To President Global AWM and Chief Human Resources Officer
Rebecca Carreon, the Executive Assistant To President Global AWM and Chief Human Resources Officer at Smith & Nephew, manages the operational logistics for the leadership overseeing advanced wound management and human capital. Carreon coordinates complex scheduling and communication flows that enable the effective administration of global human resources policies and wound care commercial strategies. By supporting the executive team, the Executive Assistant To President Global AWM and Chief Human Resources Officer ensures that talent management initiatives remain synchronized with the company's medical technology objectives. Rebecca Carreon facilitates the integration of HR programs across international regions, promoting a culture of excellence and compliance. This role involves managing sensitive information and high-priority tasks that impact the overall workforce strategy. Through meticulous organization, Carreon supports the leadership in driving organizational performance. Ultimately, the Executive Assistant To President Global AWM and Chief Human Resources Officer maintains the operational stability required to sustain global market leadership.
Rohit Kashyap - President, Advanced Wound Management & Global Commercial Operations
Rohit Kashyap, the President, Advanced Wound Management & Global Commercial Operations at Smith & Nephew, directs the commercial strategy and market expansion for the wound management division. Kashyap oversees global sales initiatives, ensuring that advanced wound care solutions reach healthcare providers and hospitals effectively. By managing commercial operations across diverse international markets, the President, Advanced Wound Management & Global Commercial Operations drives revenue growth and market penetration. Rohit Kashyap coordinates with regional teams to tailor clinical therapy offerings to local healthcare needs. This leadership role involves analyzing market dynamics to refine sales strategies and improve the adoption of medical devices. Through the execution of robust commercial plans, Kashyap strengthens the company's presence in the global wound care sector. Ultimately, the President, Advanced Wound Management & Global Commercial Operations ensures that the organization delivers high-value clinical outcomes to surgical professionals and patients worldwide.
Nayely Lobo - Chief of Staff
Nayely Lobo, the Chief of Staff at Smith & Nephew, coordinates executive workflows and facilitates communication across the senior leadership team. Lobo manages critical administrative initiatives that support the execution of corporate strategy within the medical device manufacturing sector. By streamlining internal processes, the Chief of Staff ensures that departmental goals align with the broader mission of delivering advanced healthcare solutions. Nayely Lobo monitors operational progress, providing the necessary oversight to maintain momentum on key projects related to orthopaedic and wound management portfolios. This role involves synthesizing complex data from various business units to assist in high-level decision-making. Through effective management of executive priorities, Lobo enhances organizational agility and cross-functional collaboration. Ultimately, the Chief of Staff optimizes the efficiency of the leadership office, allowing the company to focus on its core objective of improving patient outcomes through superior clinical technology.
Explore Leadership Teams in Manufacturing
Dentsply Sirona is a manufacturer of professional dental products and technologies. The company develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a portfolio of brands. Dentsply Sironas global headquarters is located in Charlotte, North Carolina.
Company Leadership DC


LS
Laerdal Medical is a Norwegian manufacturer and global leader in high-fidelity patient simulators designed for training healthcare professionals. Their mission is to help save one million lives annually by 2030, providing solutions for emergency care, intensive care, obstetrics, and neonatal care. The company offers a range of products and services, including simulation training, medical devices, and educational resources aimed at hospitals, universities, and emergency responders. Laerdal Medical empowers everyday heroes by enhancing the skills and knowledge necessary for effective patient care.
Company Leadership SS
SM
SS
As per the "buy and build" strategy, the next acquisition was Legacy Medical (July 2018), followed by Haemotec (Nov 2019) and LTE Medical Supplies (Feb 2019). In April 2019, the company started an Ophthalmology business (EyeCare) and have expanded the company's product range and agencies in the existing verticals. The second half of 2019 saw further acquisitions with Paragmed in November and Jumla Medical Supplies and Stratmed joining the group in December. The company is a scaled and diversified group of specialised medical service providers committed to bringing new, first-rate technologies to a wide spectrum of medical practitioners. The company provides the latest devices, software, processes and procedures that facilitate high care and quality treatment for all patients. The company's clients and partners continually receive extensive training and comprehensive technical support as the company strives towards better products, better services and more personalised customer experiences. Depiction of Vertice MedTech
Company Leadership HP
GS
BM
EM
Greiner Bio-One is a global leader in biotechnology, medical devices, in vitro diagnostics, and research, employing over 2300 individuals across 28 subsidiaries worldwide. The company focuses on providing innovative and high-quality product solutions tailored to the needs of its clients in the healthcare and laboratory sectors. With production facilities in multiple countries, including Austria, Germany, and the United States, Greiner Bio-One emphasizes strong customer orientation and safety in its offerings. Their extensive product range includes blood collection systems, cell culture products, and laboratory equipment designed to enhance diagnostic and research capabilities.
Company Leadership RS

HY